The Precision Peptide Company Grants RSUs and Stock Options and Settles Debt

Vancouver, British Columbia--(Newsfile Corp. - May 4, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced peptide formulations and delivery systems, announces the grant of restricted share units (the "RSUs") and incentive stock options (the "Options") pursuant to the Company's omnibus share incentive plan, as well as the issuance of common shares to settle outstanding indebtedness owed to a creditor of the Company. RSU Grant The Company has granted a total of 600,000 RSUs to certain director of the Company.